Press releases

Business produces a range of products used to manage fluid and measure pressure during angiography and angioplasty procedures

"We made progress in a number of key areas during the quarter," said Jim Tobin, President and Chief Executive Officer

TAXUS PERSEUS clinical program to evaluate platinum enhanced drug-eluting stent

Successful implantation marks the beginning of the TAXUS PETAL I First Human Use (FHU) Trial

Claims associated with a series of product communications issued by Guidant Corporation in 2005 and 2006; Company acquired Guidant Corporation last year

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2007...

Hardware and software innovations offer new benefits to physicians and patients

Acquisition to bring innovative sensor and wireless communication technology, complementing Company's Cardiac Rhythm Management product line

Deal follows successful four-year exclusive distribution of Prolieve® Thermodilatation System

A live webcast and replay of the June 13 conference session will be available

Article in April 24 edition of JACC highlights shorter procedure time, lower bailout rate

Study seeks to confirm the safety and efficacy of systems in routine clinical practice

Longest drug-eluting stent approved for the management of patients with clinically challenging coronary artery disease

SPIRIT FIRST follow-up analysis shows no stent thrombosis or MACE after one year

Study highlights importance of antiplatelet therapy compliance

Trial results report no new stent thrombosis after two years in high-risk patient population

Group supports call for limiting greenhouse gas emissions

Company anticipates broad range of clinical results on endoscopic technologies

Single-operator system allows unprecedented visual access to bile duct

Company to release broad range of clinical data on leading drug-eluting stent portfolio

More than 23,000 patients now enrolled in TAXUS OLYMPIA registry

New data provide support for minimally invasive treatment of atrial fibrillation (AF)

Data represents the industry's largest experience with wireless remote monitoring of implantable cardiac devices for one year

Reimbursement granted by National Health Insurance System

RENAISSANCE trial demonstrates durable results for Company's Express® SD Renal Stent in treating hypertensive patients with severe renal artery stenosis